Top Tweets for #CLLSM
In a recent interview at #SOHO2026, @KerryARogersMD of @OSUHematology discussed the importance of supportive care for patients with chronic lymphocytic #leukemia.
Click here to watch:
π₯ π https://t.co/HpeBZXuXEm
#CLLsm #Leusm #SuppOnc #HemOnc
Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia [Oct 25,2021] Allegra et al. @FrontImmunol https://t.co/776HcqtRMe #mmsm #CLLsm #leusm #IDonc
![mtmdphd's tweet photo. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia [Oct 25,2021] Allegra et al. @FrontImmunol https://t.co/776HcqtRMe #mmsm #CLLsm #leusm #IDonc https://t.co/kBsNiCEoae](https://pbs.twimg.com/media/HSbrz_1WcAA_Y6W.jpg)
"...need to develop more effective vaccine strategies in this population of Pts at high risk for infection" [Jul 2014] Whitaker et al. @clinadvances https://t.co/8Fs72Zd0w4 #leusm #CLLsm #IDonc
Room for Improvement: Immunization for Pts w/ Monoclonal B-Cell Lymphocytosis or CLL [Jul 2014] Whitaker et al. @clinadvances https://t.co/8Fs72Zd0w4 #leusm #CLLsm #IDonc


Chemotherapy-free regimens for Richter transformation: a bridge, but not yet a destination [Sep 10, 2026] @HannahGoulart @DrMDavids @NitinJainMD @Haematologica https://t.co/rTNhFFnqV7 #NCT04082897 #CLLsm #leusm #caxtx
![mtmdphd's tweet photo. Chemotherapy-free regimens for Richter transformation: a bridge, but not yet a destination [Sep 10, 2026] @HannahGoulart @DrMDavids @NitinJainMD @Haematologica https://t.co/rTNhFFnqV7 #NCT04082897 #CLLsm #leusm #caxtx https://t.co/6d7bT8OeDy](https://pbs.twimg.com/media/HR8oPzXaUAA0VYP.png)
PIVOT-CLL - Pirobrutinib, Venetoclax, Obinotuzumab Treatment in First Line CLL [Sep 10, 2026] @NitinJainMD #SOHO2026 #CLLsm #leusm #caxtx Conclusions
![mtmdphd's tweet photo. PIVOT-CLL - Pirobrutinib, Venetoclax, Obinotuzumab Treatment in First Line CLL [Sep 10, 2026] @NitinJainMD #SOHO2026 #CLLsm #leusm #caxtx Conclusions https://t.co/OTF3PngtTV](https://pbs.twimg.com/media/HR5Qmq3XAAYciVS.jpg)
PIVOT-CLL - Pirobrutinib, Venetoclax, Obinotuzumab Treatment in First Line CLL [Sep 10, 2026] @NitinJainMD #SOHO2026 #CLLsm #leusm #caxtx PFS & OS
![mtmdphd's tweet photo. PIVOT-CLL - Pirobrutinib, Venetoclax, Obinotuzumab Treatment in First Line CLL [Sep 10, 2026] @NitinJainMD #SOHO2026 #CLLsm #leusm #caxtx PFS & OS https://t.co/jS26zwaIFq](https://pbs.twimg.com/media/HR5PLCTbEAAjh9p.jpg)
PIVOT-CLL - Pirobrutinib, Venetoclax, Obinotuzumab Treatment in First Line CLL [Sep 10, 2026] @NitinJainMD #SOHO2026 #CLLsm #leusm #caxtx MRD
![mtmdphd's tweet photo. PIVOT-CLL - Pirobrutinib, Venetoclax, Obinotuzumab Treatment in First Line CLL [Sep 10, 2026] @NitinJainMD #SOHO2026 #CLLsm #leusm #caxtx MRD https://t.co/PJIu0HnisD](https://pbs.twimg.com/media/HR5O_DQX0AIABfS.jpg)
PIVOT-CLL - Pirobrutinib, Venetoclax, Obinotuzumab Treatment in First Line CLL [Sep 10, 2026] @NitinJainMD #SOHO2026 #CLLsm #leusm #caxtx
![mtmdphd's tweet photo. PIVOT-CLL - Pirobrutinib, Venetoclax, Obinotuzumab Treatment in First Line CLL [Sep 10, 2026] @NitinJainMD #SOHO2026 #CLLsm #leusm #caxtx https://t.co/a8OmRHAlul](https://pbs.twimg.com/media/HR5Ok3MaIAA2BfB.jpg)
Great CLL poster walk! I saved the best poster for last (helps make my argument for my debate later on venetoclax retreatment!) #SOHO26 #SOHO2026 #cllsm @HemSandoval

π¨ our multiregional expert consensus report on treatment selection in chronic lymphocytic leukemia (CLL) has just been published online in Blood Global Hematology π€π
#CLLsm
@BloodPortfolio @ASH_hematology
https://t.co/6KeHnq6LBz
In an interview from #EHA2026, @DrMDavids of @DanaFarber discusses the evolving treatment landscape of chronic lymphocytic #leukemia and the potential path towards curative approaches for this disease.
Watch the interview here:
π₯ β‘οΈ https://t.co/L6Lc5emaYm
#CLLsm #HemOnc #Leusm
π₯ In an interview from #ASCO26, Supriya Gupta (@UMNews) discusses the potential of azer-cel, an allogeneic #CARTCell therapy for treating #NonHodgkinLymphoma and chronic lymphocytic #leukemia.
Watch here:
π https://t.co/O9zl4Vwhj0
#Lymphoma #LYMsm #CLLsm #Leusm #ImmunoOnc
Genomic profiling reveals molecular heterogeneity in patients with Richter transformation (RT) and chronic lymphocytic leukemia (CLL) [Nov 11, 2025] Tian et al. Leukemia Res https://t.co/meVdj1BQ9c #CLLsm #leusm #PrecisionMedicine @TempusAI @MayoCancerCare
![mtmdphd's tweet photo. Genomic profiling reveals molecular heterogeneity in patients with Richter transformation (RT) and chronic lymphocytic leukemia (CLL) [Nov 11, 2025] Tian et al. Leukemia Res https://t.co/meVdj1BQ9c #CLLsm #leusm #PrecisionMedicine @TempusAI @MayoCancerCare https://t.co/ytqxU0aamU](https://pbs.twimg.com/media/HPeCPBYWwAAmOnx.jpg)
#Hematology Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004 #lymsm #CLLsm #CARTcell https://t.co/IRi9rIRdh9
Last Seen Hashtags on Sotwe
redesigninghumanity
Seen from United States
iyfinkl
Seen from United States
SnapCar
Seen from United States
nyloncorap
Seen from Turkey
nsfwtwt
sotme
Seen from Australia
Mature thai
Seen from Switzerland
angelawhite #brazzers
Seen from Turkey
cholitas(*)+filter:media
Seen from United States
frieren
Seen from United States
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.4M followers

Virat Kohli 
@imvkohli
73.3M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.1M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers



![mtmdphd's tweet photo. Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma [Oct 1, 2024] @mshadman et al. Leuk Lymphoma https://t.co/xaIScFxagJ #CLLsm #leusm #hpeonc https://t.co/0cCjmzaIsl](https://pbs.twimg.com/media/HR5BYNnXQAIrfmG.jpg)



